COMMON STOCK PURCHASE WARRANT PRECISION THERAPEUTICS INC.Common Stock Purchase • November 16th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, the Holder (as defined below), [NAME OF HOLDER] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 3, 2019 (“Issuance Date”), to purchase from Precision Therapeutics Inc., a Delaware corporation (the “Company”), up to [______________] shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price (defined below) per share then in effect. This Warrant is one of the Warrants (the “Warrants”) issued pursuant to the Warrant Agency Agreement, dated as of April 3, 2019, by and between the Company and Corporate Stock Transfer, Inc. (the “Warrant Agent”) (the “Warrant Agency Agreement”) in connection with the exchange offer to holders of warrants of Helomics Holding Corporation.
